Rothschild & CO Asset Management Us Inc. Ironwood Pharmaceuticals Inc Transaction History

Rothschild & CO Asset Management Us Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 08, 2018	SELL	$11.13 - $13.63 $13.7 Million - $16.7 Million	-1,227,233 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$12.16 - $14.58 $464,974 - $557,510	-38,238 Reduced 3.02%	1,227,233 $18.4 Million
Q3 2017 Nov 08, 2017	BUY	$12.07 - $14.87 $15.3 Million - $18.8 Million	1,265,471	1,265,471 $20 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.